Surrey, Canada

Dev Mitra Ranji Singh

This inventor holds 2 USPTO granted patents. Top assignees: Qlt Inc., Valeant Pharmaceuticals International. Active years: 2006-2014.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dev Mitra Ranji Singh: Innovator in Drug Delivery Systems

Introduction

Dev Mitra Ranji Singh is a notable inventor based in Surrey, Canada. He has made significant contributions to the field of drug delivery systems, particularly focusing on hydrophobic drugs. With a total of 2 patents, Singh's work has the potential to enhance the efficacy of drug administration.

Latest Patents

Singh's latest patents include a groundbreaking drug delivery system for hydrophobic drugs. This invention describes compositions comprising microaggregates that contain hydrophobic drugs, as well as methods for their production. The microaggregates may include micelle structures or combinations thereof with liposomes, serving as an effective delivery vehicle for hydrophobic agents. The methods for producing these microaggregates involve the use of preferred lipid compounds and processing conditions that favor the creation of small aggregates, which improve filter sterilization.

Career Highlights

Throughout his career, Singh has worked with prominent companies in the pharmaceutical industry, including Valeant Pharmaceuticals International and QLT Inc. His experience in these organizations has allowed him to develop innovative solutions that address critical challenges in drug delivery.

Collaborations

Singh has collaborated with notable professionals in his field, including Ronald Erwin Boch and Iman Karmadi. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Dev Mitra Ranji Singh is a distinguished inventor whose work in drug delivery systems has the potential to revolutionize the administration of hydrophobic drugs. His innovative approaches and collaborations highlight his commitment to advancing pharmaceutical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…